4th Circ. Backs Dismissal of Takeda Whistleblower Suit
The Fourth Circuit on Friday ruled that a Takeda Pharmaceuticals North America Inc. sales leader could not proceed with his whistleblower lawsuit against the pharmaceutical giant accusing it of allowing off-label...To view the full article, register now.
Already a subscriber? Click here to view full article